<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35212556</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1092-874X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Season>Mar-Apr</Season>
            </PubDate>
          </JournalIssue>
          <Title>International journal of toxicology</Title>
          <ISOAbbreviation>Int J Toxicol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of Illicit Drug Seizures Products of Natural Origin Using a Molecular Networking Approach.</ArticleTitle>
        <Pagination>
          <StartPage>108</StartPage>
          <EndPage>114</EndPage>
          <MedlinePgn>108-114</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/10915818211065161</ELocationID>
        <Abstract>
          <AbstractText>Drug powder composition analysis is of particular interest in forensic investigations to identify illicit substance content, cutting agents and impurities. Powder profiling is difficult to implement due to multiple analytical methods requirement and remains a challenge for forensic toxicology laboratories. Furthermore, visualization tools allowing seizure products identification appear to be under-used to date. The aim of this study is to present the utility of molecular networking for the composition establishment of natural origin drugs. A powder suspected to contain heroin and three powders suspected to contain cocaine obtained from law enforcement agency seizures were analyzed using untargeted screening by liquid chromatography coupled with high-resolution mass spectrometry (LC-HRMS/MS). Molecular networking and metabolite annotation applied to suspected heroin sample allowed rapid confirmation of its illicit content (heroin), the identification of structurally related major impurities (6-monoacetylmorphine, 6-monoacetylcodeine, noscapine, and papaverine), as well as cutting agents (acetaminophen and caffeine). The cocaine powder profiling allowed the comparison of its constituents in a semi-quantitative manner (cocaine, benzoylecgonine, trans/cis-cinnamoylcocaine, trimethoxycocaine, hexanoylecgonine methylester, caffeine, hydroxyzine, levamisole, and phenacetin), bringing additional information for their identification, including geographically sourcing of natural product and their putative place in the supply chain. Although this approach does not replace the profiling techniques used by forensic laboratories, the use of molecular networks provides a visual overview of structurally related constituents which aids the comparison and investigation of seizure powders. Molecular networks offers here an ideal way to depict structurally related and unrelated compounds in these often complex mixtures of chemicals.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Le Daré</LastName>
            <ForeName>Brendan</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0002-5907-2450</Identifier>
            <AffiliationInfo>
              <Affiliation>Forensic Toxicology Laboratory, 36684Rennes University Hospital, Rennes, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM, INRA, CHU Rennes, Institut NuMeCan (Nutrition, Metabolisms and Cancer), 36684University Rennes, Rennes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allard</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Forensic Toxicology Laboratory, 36684Rennes University Hospital, Rennes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Couette</LastName>
            <ForeName>Aurélien</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Forensic Toxicology Laboratory, 36684Rennes University Hospital, Rennes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allard</LastName>
            <ForeName>Pierre-Marie</ForeName>
            <Initials>PM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, 27211University of Fribourg, Fribourg, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morel</LastName>
            <ForeName>Isabelle</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Forensic Toxicology Laboratory, 36684Rennes University Hospital, Rennes, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM, INRA, CHU Rennes, Institut NuMeCan (Nutrition, Metabolisms and Cancer), 36684University Rennes, Rennes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gicquel</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Forensic Toxicology Laboratory, 36684Rennes University Hospital, Rennes, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM, INRA, CHU Rennes, Institut NuMeCan (Nutrition, Metabolisms and Cancer), 36684University Rennes, Rennes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Int J Toxicol</MedlineTA>
        <NlmUniqueID>9708436</NlmUniqueID>
        <ISSNLinking>1091-5818</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013287">Illicit Drugs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>362O9ITL9D</RegistryNumber>
          <NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3G6A5W338E</RegistryNumber>
          <NameOfSubstance UI="D002110">Caffeine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>70D95007SX</RegistryNumber>
          <NameOfSubstance UI="D003932">Heroin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002110" MajorTopicYN="N">Caffeine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003932" MajorTopicYN="N">Heroin</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013287" MajorTopicYN="Y">Illicit Drugs</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cocaine</Keyword>
        <Keyword MajorTopicYN="N">drug seizure</Keyword>
        <Keyword MajorTopicYN="N">heroin</Keyword>
        <Keyword MajorTopicYN="N">high-resolution mass spectrometry</Keyword>
        <Keyword MajorTopicYN="N">molecular networking</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>12</Hour>
          <Minute>15</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35212556</ArticleId>
        <ArticleId IdType="doi">10.1177/10915818211065161</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
